501 related articles for article (PubMed ID: 20549648)
21. Transcriptional regulation of Smad2 is required for enhancement of TGFbeta/Smad signaling by TGFbeta inducible early gene.
Johnsen SA; Subramaniam M; Katagiri T; Janknecht R; Spelsberg TC
J Cell Biochem; 2002; 87(2):233-41. PubMed ID: 12244575
[TBL] [Abstract][Full Text] [Related]
22. A novel inhibitor of Smad-dependent transcriptional activation suppresses tissue fibrosis in mouse models of systemic sclerosis.
Hasegawa M; Matsushita Y; Horikawa M; Higashi K; Tomigahara Y; Kaneko H; Shirasaki F; Fujimoto M; Takehara K; Sato S
Arthritis Rheum; 2009 Nov; 60(11):3465-75. PubMed ID: 19877032
[TBL] [Abstract][Full Text] [Related]
23. Fibroblast expression of the coactivator p300 governs the intensity of profibrotic response to transforming growth factor beta.
Bhattacharyya S; Ghosh AK; Pannu J; Mori Y; Takagawa S; Chen G; Trojanowska M; Gilliam AC; Varga J
Arthritis Rheum; 2005 Apr; 52(4):1248-58. PubMed ID: 15818659
[TBL] [Abstract][Full Text] [Related]
24. Autosomal dominant polycystic kidney disease (ADPKD, MIM 173900, PKD1 and PKD2 genes, protein products known as polycystin-1 and polycystin-2).
Boucher C; Sandford R
Eur J Hum Genet; 2004 May; 12(5):347-54. PubMed ID: 14872199
[TBL] [Abstract][Full Text] [Related]
25. Transforming growth factor beta signalling and matrix metalloproteinases in the mucosa overlying Crohn's disease strictures.
Di Sabatino A; Jackson CL; Pickard KM; Buckley M; Rovedatti L; Leakey NA; Picariello L; Cazzola P; Monteleone G; Tonelli F; Corazza GR; MacDonald TT; Pender SL
Gut; 2009 Jun; 58(6):777-89. PubMed ID: 19201776
[TBL] [Abstract][Full Text] [Related]
26. Autosomal dominant polycystic kidney disease: clinical and genetic aspects.
Sessa A; Ghiggeri GM; Turco AE
J Nephrol; 1997; 10(6):295-310. PubMed ID: 9442442
[TBL] [Abstract][Full Text] [Related]
27. Renal extracellular matrix accumulation in acute puromycin aminonucleoside nephrosis in rats.
Jones CL; Buch S; Post M; McCulloch L; Liu E; Eddy AA
Am J Pathol; 1992 Dec; 141(6):1381-96. PubMed ID: 1281619
[TBL] [Abstract][Full Text] [Related]
28. Role of the TGF-β/BMP-7/Smad pathways in renal diseases.
Meng XM; Chung AC; Lan HY
Clin Sci (Lond); 2013 Feb; 124(4):243-54. PubMed ID: 23126427
[TBL] [Abstract][Full Text] [Related]
29. Cross talk between lysine methyltransferase Smyd2 and TGF-β-Smad3 signaling promotes renal fibrosis in autosomal dominant polycystic kidney disease.
Li LX; Zhang L; Agborbesong E; Zhang X; Zhou JX; Li X
Am J Physiol Renal Physiol; 2022 Aug; 323(2):F227-F242. PubMed ID: 35759739
[TBL] [Abstract][Full Text] [Related]
30. Cux1 promotes cell proliferation and polycystic kidney disease progression in an ADPKD mouse model.
Porath B; Livingston S; Andres EL; Petrie AM; Wright JC; Woo AE; Carlton CG; Baybutt R; Vanden Heuvel GB
Am J Physiol Renal Physiol; 2017 Oct; 313(4):F1050-F1059. PubMed ID: 28701314
[TBL] [Abstract][Full Text] [Related]
31. Immortalized epithelial cells from human autosomal dominant polycystic kidney cysts.
Loghman-Adham M; Nauli SM; Soto CE; Kariuki B; Zhou J
Am J Physiol Renal Physiol; 2003 Sep; 285(3):F397-412. PubMed ID: 12734101
[TBL] [Abstract][Full Text] [Related]
32. Ablation of Long Noncoding RNA Hoxb3os Exacerbates Cystogenesis in Mouse Polycystic Kidney Disease.
Weisser I; Eckberg K; D'Amico S; Buttram D; Aboudehen K
J Am Soc Nephrol; 2024 Jan; 35(1):41-55. PubMed ID: 37953472
[TBL] [Abstract][Full Text] [Related]
33. Defining a link with autosomal-dominant polycystic kidney disease in mice with congenitally low expression of Pkd1.
Jiang ST; Chiou YY; Wang E; Lin HK; Lin YT; Chi YC; Wang CK; Tang MJ; Li H
Am J Pathol; 2006 Jan; 168(1):205-20. PubMed ID: 16400024
[TBL] [Abstract][Full Text] [Related]
34. Differences in the timing and magnitude of Pkd1 gene deletion determine the severity of polycystic kidney disease in an orthologous mouse model of ADPKD.
Rogers KA; Moreno SE; Smith LA; Husson H; Bukanov NO; Ledbetter SR; Budman Y; Lu Y; Wang B; Ibraghimov-Beskrovnaya O; Natoli TA
Physiol Rep; 2016 Jun; 4(12):. PubMed ID: 27356569
[TBL] [Abstract][Full Text] [Related]
35. TAZ/Wnt-β-catenin/c-MYC axis regulates cystogenesis in polycystic kidney disease.
Lee EJ; Seo E; Kim JW; Nam SA; Lee JY; Jun J; Oh S; Park M; Jho EH; Yoo KH; Park JH; Kim YK
Proc Natl Acad Sci U S A; 2020 Nov; 117(46):29001-29012. PubMed ID: 33122431
[TBL] [Abstract][Full Text] [Related]
36. Identification of porcine polycystic kidney disease 1 (PKD1) gene: molecular cloning, expression profile, and implication in disease model.
He J; Wang Q; Ye J; Hu X; Li N
Gene; 2011 Dec; 490(1-2):37-46. PubMed ID: 21945688
[TBL] [Abstract][Full Text] [Related]
37. A mouse model for polycystic kidney disease through a somatic in-frame deletion in the 5' end of Pkd1.
Starremans PG; Li X; Finnerty PE; Guo L; Takakura A; Neilson EG; Zhou J
Kidney Int; 2008 Jun; 73(12):1394-405. PubMed ID: 18385665
[TBL] [Abstract][Full Text] [Related]
38. Cyst expansion and regression in a mouse model of polycystic kidney disease.
Happé H; van der Wal AM; Salvatori DC; Leonhard WN; Breuning MH; de Heer E; Peters DJ
Kidney Int; 2013 Jun; 83(6):1099-108. PubMed ID: 23466997
[TBL] [Abstract][Full Text] [Related]
39. N-myc downstream-regulated gene 1 is involved in the regulation of cystogenesis in transgenic mice overexpressing human PKD2 gene.
Kim BH; Park EY; Yoo KH; Choi KM; Kim Y; Seong Jk; Park JH
Proteomics; 2013 Jan; 13(1):134-41. PubMed ID: 23212942
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of exogenous kidney-specific Ngal attenuates progressive cyst development and prolongs lifespan in a murine model of polycystic kidney disease.
Wang E; Chiou YY; Jeng WY; Lin HK; Lin HH; Chin HJ; Leo Wang CK; Yu SS; Tsai SC; Chiang CY; Cheng PH; Lin HJ; Jiang ST; Chiu ST; Hsieh-Li HM
Kidney Int; 2017 Feb; 91(2):412-422. PubMed ID: 28341240
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
